Emergent Biosolutions Inc [NYSE: EBS] slipped around -0.49 points on Thursday, while shares priced at $2.77 at the close of the session, down -15.03%. The company report on March 6, 2024 at 4:31 PM that Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results. Fourth Quarter
Emergent Biosolutions Inc [NYSE: EBS] gained 15.79% or 0.45 points to close at $3.30 with a heavy trading volume of 5159230 shares. The company report on February 21, 2024 at 7:00 AM that Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and
Emergent Biosolutions Inc [NYSE: EBS] gained 78.29% on the last trading session, reaching $2.71 price per share at the time. The company report on February 21, 2024 at 7:00 AM that Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO. Papa
© 2024, Powered by Smart TechOne
